Rho GTPases as therapeutic targets in cancer and other human diseases

被引：0

作者：

Lorenzano Menna, Pablo ^{[1
]}

Cardama, Georgina A. ^{[1
]}

Comin, Maria J. ^{[2
]}

Alonso, Daniel F. ^{[1
]}

Gomez, Daniel E. ^{[1
]}

机构：

[1] Univ Nacl Quilmes, Oncol Mol Lab, Dept Ciencia & Tecnol, RA-1876 Buenos Aires, DF, Argentina

[2] INTI, Ctr Invest & Desarrollo Quim, Buenos Aires, DF, Argentina

来源：

MEDICINA-BUENOS AIRES | 2010年 / 70卷 / 06期

关键词：

cell signaling; cytoskeleton; cell migration; neurodegenerative diseases; cancer; PROTEIN-KINASE-C; MAMMARY-CARCINOMA CELLS; GDP EXCHANGE FACTOR; ANTIESTROGEN RESISTANCE; BREAST-CANCER; RAC3; GTPASES; ACTIVATION; RAS; TIAM1; INHIBITORS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rho GTPases as therapeutic targets in cancer and other human diseases. Rho GTPases are a key protein family controlling the transduction of external signals to cytoplasmatic and nuclear effectors. In the last few years, the development of genetic and pharmacological tools has allowed a more precise definition of the specific roles of Rho GTPases. The aim of this review is to describe the cellular functions regulated by these proteins with focus on the molecular mechanism involved. We also address the role of Rho GTPases in the development of different human diseases such as cancer. Finally, we describe different experimental therapeutic strategies with Rho GTPases as molecular targets.

引用

页码：555 / 564

页数：10

共 50 条

[1] Rho GTPases as therapeutic targets for the treatment of inflammatory diseases
Zhao, DZ
Pothoulakis, C
[J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (05) : 583 - 592
[2] Rho GTPases as therapeutic targets in cancer (Review)
Cardama, G. A.
Gonzalez, N.
Maggio, J.
Lorenzano Menna, P.
Gomez, D. E.
[J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (04) : 1025 - 1034
[3] Rho-family GTPases as therapeutic targets in ovarian cancer
Hudson, L. G.
Kenney, S. R.
Guo, Y.
Adams, S.
Rutledge, T.
Muller, C. Y.
Wandinger-Ness, A.
[J]. CLINICAL CANCER RESEARCH, 2015, 21
[4] Rho GTPases as molecular targets in cancer. Strategies and therapeutic opportunities
Maggio, Julian
Gonzalez, Nazareno
Cardama, Georgina A.
Gomez, Daniel E.
[J]. MEDICINA-BUENOS AIRES, 2017, 77 (06) : 497 - 504
[5] Rho GTPases as therapeutic targets in Alzheimer's disease
Aguilar, Byron J.
Zhu, Yi
Lu, Qun
[J]. ALZHEIMERS RESEARCH & THERAPY, 2017, 9
[6] Rho GTPases as therapeutic targets in Alzheimer’s disease
Byron J. Aguilar
Yi Zhu
Qun Lu
[J]. Alzheimer's Research & Therapy, 9
[7] Rho GTPases in neurodegeneration diseases
DeGeer, Jonathan
Lamarche-Vane, Nathalie
[J]. EXPERIMENTAL CELL RESEARCH, 2013, 319 (15) : 2384 - 2394
[8] RHO–GTPases and cancer
Erik Sahai
Christopher J. Marshall
[J]. Nature Reviews Cancer, 2002, 2 : 133 - 142
[9] Rho GTPases and cancer
Li, Hui
Peyrollier, Karine
Kilic, Gulcan
Brakebusch, Cord
[J]. BIOFACTORS, 2014, 40 (02) : 226 - 235
[10] Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer
Cervantes-Villagrana, Rodolfo Daniel
Garcia-Jimenez, Irving
Vazquez-Prado, Jose
[J]. CELLULAR SIGNALLING, 2023, 109

← 1 2 3 4 5 →